Intravenous Maintenance Fluid Therapy in the Pediatric Acute and Critical Care Setting: A European Practice Survey. Intravenous Maintenance Fluids in Pediatric Practice: A European Survey
Abstract Background: The ideal fluid for intravenous maintenance fluid therapy (IV-MFT) in acutely and critically ill children is controversial and evidence based clinical practice guidelines are lacking. The current prescribing practices remains unknown.Aim: We aimed to describe the current practices and choice of pediatric acute care clinicians in prescribing IV-MFT in the context of acutely and critically ill children with regards to the amount, tonicity, composition, use of balanced fluid and prescribing strategies in various clinical contexts. Method: A cross-sectional electronic survey was emailed in April-May 2021 to pediatric critical care physicians across European and Middle East countries. The survey instrument was developed by an expert multi-professional panel within ESPNIC. The survey instrument included their practice of prescribing the IV-MFT: indication, amount, tonicity, use of balance solutions & composition of IV-MFT.Results: 154 respondents from 35 European and Middle East countries participated in this survey (response rate 64%). Respondents were staff physicians or nurse practitioners in charge of critically ill children. They all indicated that they routinely use a predefined formula to prescribe the amount of an IV-MFT. The use of balanced solution was preferred in case of altered serum Na and Cl levels or metabolic acidosis. 42% of responders (65/153) believed that balanced solutions should always be used. In terms of the indication and the composition of IV-MFT prescribed, responses were heterogenous among centers. 70% of the respondents (n=107) believed there was a gap between the current practice in their unit and what they considered ideal IV-MFT due to the lack of guidelines and inadequate training of health care professionals.Conclusion: Our study showed considerable variability in clinical prescribing practice of IV-MFT in PICUs across Europe and the middle east. There is an urgent need to develop evidence-based guidelines for IV-MFT prescription in acutely and critically ill children.